Patents for C12R 1 - Micro-organisms (92,025)
05/2005
05/17/2005US6893839 Isolated cyclohexadepsipeptide synthetases and isolated nucleic acid sequences encoding the cyclohexadepsipeptide synthetases
05/17/2005CA2158017C Production of glycolate oxidase in methylotrophic yeast
05/12/2005WO2005042720A2 Kahalalide-producing bacteria
05/12/2005US20050100996 Using ethanologenic microorganism comprising raw starch hydrolyzing glucoamylase as bioreactor for production of ethanol; alcoholic beverages
05/12/2005US20050100984 Expression vector comprising nucleotide sequences coding immunoglobulin fusion directed towards tumors for use in treatment and prevention of cell proliferative disorders; tissue targeted therapy; immunotherapy
05/12/2005US20050100927 Using transgenic corynebacterium which over expresses dihydropicolinate synthase to ferment lysine for use in cosmetics, medicines and animal feeds
05/12/2005US20050100540 Platelet-activating factor acetylhydrolase
05/11/2005EP1529114A1 Process for preparing peptides with anti-hypertensive properties
05/11/2005EP1070117B1 Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase
05/11/2005EP1036190B1 A method for producing hydroxycarboxylic acids by auto-degradation of polyhydroxyalkanoates
05/11/2005EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
05/11/2005EP0670373B1 Probe for diagnosing candida-infections
05/11/2005EP0625200B1 Biosynthetic binding protein for cancer marker
05/11/2005CN1615366A Production of biodegradable thermoplastic materials from organic wastes
05/11/2005CN1615360A Process for producing l-amino acid using escherichia
05/11/2005CN1614006A Thermophilic denitrifying bacillocin, screening and use thereof
05/11/2005CN1201017C Oligonucleotide primers for effectively inserse recording HCV RNA and use thereof
05/11/2005CN1201004C HER-2/neu fusion proteins
05/10/2005US6891037 Method for the isolation of polysaccharides
05/10/2005US6890754 Glycosylated collagen and fibroblast lattice containing keratinocytes; model for skin regeneration
05/10/2005US6890752 Synthases
05/10/2005US6890710 For treating influenza infections in vivo; fusion proteins; solid phase synthesis
05/10/2005US6890572 Bacillus culture product; baked goods
05/10/2005US6890529 Edible foods, functional products or pharmaceuticals; nutraceutical; beverages
05/10/2005CA2118518C Over expression of single-stranded molecules
05/10/2005CA1341482C Process for preparing fragments of aids-associated retroviruses
05/06/2005WO2004110933A3 Dehalococcoides isolate for bioremediation
05/05/2005US20050097635 Nucleotide sequences coding crystal protein for use in generating insect resistant crop plants; biological pest control
05/05/2005US20050096229 Biocidal compounds and their preparation
05/05/2005US20050095713 Vectors for gene mutagenesis and gene discovery
05/05/2005US20050095692 Generation and recovering of preferential viral particles; obtain cells, infect with virus, extract virus from cells using detergent, recover virus
05/05/2005US20050095686 Preparing starch composition to improve structure, texture and stability of food; for use in prevention and treatment of infection, immunological and tumor disorders
05/05/2005US20050095584 Method for determining early HCV seroconversion
05/05/2005US20050095318 Mixture of propionibacterium jensenii and lactobacillus sp. with antimicrobial activities for the use as natural preservation system
05/05/2005US20050095256 Nucleotide sequence encoding merozoite surface protein-1 of plasmodium strain with reduced adenine and thymine; vectors, organisms, host cells
05/05/2005US20050095249 Protein markers for lung cancer and use thereof
05/04/2005EP1528108A1 Method for producing l-cysteine using bacteria belonging to the genus Escherichia
05/04/2005EP1154979B1 Microbial process for preparing pravastatin
05/04/2005EP1124984A4 Host cells expressing recombinant human erythropoietin
05/04/2005EP1042449B1 Microorganism, method for obtaining same and feed additive
05/04/2005EP0966969B1 Anti-stress drugs and functional foods having anti-stress effects
05/04/2005EP0941227B9 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
05/04/2005EP0781340B1 Vaccine against group A Streptococcal infection
05/04/2005EP0777737B1 Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
05/04/2005EP0668916B1 Haemophilus outer membrane protein
05/04/2005EP0456706B1 Molecular methods of hybrid seed production
05/04/2005CN1612933A Method for the production of an aqueous acrylamide solution with a bio-catalyst
05/04/2005CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours
05/04/2005CN1611601A Tripeptidyl aminopeptidase
05/04/2005CN1200109C Process for preparing fat oil contg. unsaturated fatty acid
05/03/2005US6887697 D-aminoacylase and gene encoding the same
05/03/2005US6887691 DNA coding for protein which confers on bacterium Escherichia coli resistance to L-homoserine, and method for producing L-amino acids
05/03/2005US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis
05/03/2005US6887483 Non-toxic mutants of pathogenic gram-negative bacteria
05/03/2005CA2147623C Novel p-selectin ligand protein
05/03/2005CA2128215C Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
04/2005
04/28/2005WO2005038038A1 Process for producing ascorbic acid glycoside
04/28/2005US20050090535 Epothilones C, D, E and F, preparation and compositions
04/28/2005US20050090002 Serum free medium for chondrocyte-like cells
04/28/2005US20050089989 Mutant Pseudomonas putida strains and methods of use thereof
04/28/2005US20050089984 Having a specific amino acid sequence, especially fused to a heterologous polypeptide; induces apoptosis
04/28/2005US20050089968 Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
04/28/2005US20050089967 Mutant tyrosine repressor gene and utilization thereof
04/28/2005US20050089966 Chemically modified enzymes with multiple charged variants
04/28/2005US20050089954 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening
04/28/2005US20050089538 Carcinoembryonic antigen (CEA); administering a humanized Class III, anti-CEA, monoclonal antibody to treat cancer; complementarity-determining regions (CDR) of given amino acid sequences; diagnostic and therapeutic conjugates; transformed cells
04/28/2005US20050089531 Two types of foreign genes inserted in such a manner as to allow the expression into two different regions in the recombinant feline herpesvirus type 1 genome
04/28/2005US20050087489 Isolated marine planctomycetes convert ammonia to nitrogen
04/27/2005EP1526182A2 Subtilisin variants
04/27/2005EP1526181A1 Method for producing l-amino acid using bacteria belonging to the genus escherichia
04/27/2005EP1526179A1 Method for producing l-amino acid using bacteria belonging to the genus escherichia
04/27/2005EP1525303A1 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis
04/27/2005EP1525300A2 Methods for producing ethanol from carbon substrates
04/27/2005EP1127104A4 Method for the massive culture of cells producing recombinant human erythropoietin
04/27/2005EP1016709B1 Lactobacillus helveticus bacterium having high capability of producing tripeptide, fermented milk product, and process for preparing the same
04/27/2005EP1005529B1 Methods for lyophilizing competent cells
04/27/2005EP0939818B1 Recombinant toxin fragments
04/27/2005EP0877801B1 Morphological mutants of filamentous fungi
04/27/2005EP0759981B1 A method of cultivating bacteria producing proteins that are expressed in a temperature regulated manner
04/27/2005EP0743983B1 Mammalian thymokine genes
04/27/2005EP0670896B2 Cloning and expression of biologically active alpha-galactosidase a
04/27/2005CN1610751A Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
04/27/2005CN1198941C Process for preparation of derivatives of ruscus aculeatus steroid glycosides by enzymatic hydrolysis
04/27/2005CN1198936C Alzheimer's disease secretase
04/27/2005CN1198935C Method for prodn, of 1,3-propanediol by recombinant organisms
04/27/2005CN1198932C Streptococcus pneumoniae antigens
04/27/2005CN1198931C MOraxella catarrhalis BASB034 polypeptides and uses thereof
04/27/2005CN1198930C Process for preparing doxorubicin
04/27/2005CN1198924C Expression cloning in filamentous fungi
04/27/2005CN1198923C Thermostable endo-beta-1,4-glucanase
04/27/2005CN1198919C Method of producing L-serine by fermentation
04/27/2005CN1198918C Live attenuated bacteria of species actinobacillus pleuropneumoniae
04/27/2005CN1198913C Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in the active site loop region
04/27/2005CN1198912C Bleaching compositions comprising multiply-substd, protease variants
04/27/2005CN1198836C Nucleic acids encoding G-protein coupled receptor involved in sensory
04/27/2005CN1198648C High affinity human monoclonal antibodies specific for RSV F-protein
04/27/2005CN1198642C Pharmaceutical application of mammal cell kinetin synthetic inhibitory factor
04/27/2005CN1198641C Antistress agents and functional foods
04/26/2005US6884618 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
04/26/2005US6884616 DNA-construct for the tissue-specific expression of a blood coagulation factor